Biotech Analyst Kluska holds a meeting with management in New York on September 5 hosted by Cantor Fitzgerald.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKYE:
- Skye Bioscience to Participate in Upcoming Healthcare Investment Conferences
- Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab, in Patients with Obesity
- Skye Bioscience launches Phase 2 CBeyond trial of nimacimab
- Skye Bioscience Reports Second Quarter 2024 Financial Results and Recent Highlights